Status:
COMPLETED
Uterine Artery Blood Flow in Pregnant Women With PCOS Treated With Metformin
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
St. Olavs Hospital
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-45 years
Phase:
PHASE3
Brief Summary
FlowMet study is a "sub-study" of the PregMet study (registered in 2005). The aim of the FlowMet study is to register the possible effect of metformin on the blood flow of the uterine artery in pregn...
Eligibility Criteria
Inclusion
- Same as in the PregMet study. As this study is a sub-study/extended study of the PregMet study, ONLY those included in the PregMet study (NCT00159536) can participate.
Exclusion
- Same as in the PregMet study
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00466622
Start Date
April 1 2007
End Date
February 1 2010
Last Update
July 20 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Obstetrics and Gynecology, National Center for fetal Medicine, University Hospital of Trondheim
Trondheim, Norway, 7006